Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PANACEA LIFE SCIENCES HOLDINGS, INC.EXDI · Entity 9699 | PRESIDENT AND INTERIM CEO | September 13, 2019 | October 07, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PANACEA LIFE SCIENCES HOLDINGS, INC.
Report date September 13, 2019 · Filed October 07, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,000,000 |
Reported balance
After 2019-09-13 transaction · row 1
1 source rowRow 1 · 2019-09-13 · Grant · Acquired 1,000,000 · Balance 1,000,000 F1: Award of shares of restricted common stock that commence vesting upon the satisfaction of certain performance conditions, after which the shares shall vest equally over 48 months. |
| Options to purchase common stockSEC Table II · derivative / convertible security · Conversion / exercise price $0.32 · Expires 2029-01-09 | Direct | 250,000 |
Reported balance
Holding disclosure · report date 2019-09-13 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 250,000 |
Filing footnotes · ownership attribution and instrument terms
F1: Award of shares of restricted common stock that commence vesting upon the satisfaction of certain performance conditions, after which the shares shall vest equally over 48 months.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 13, 2019 Filed Oct 7, 2019 16:47 UTC | PANACEA LIFE SCIENCES HOLDINGS, INC. EXDI · Entity 9699 | GrantCommon Stock | 1,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-19-001156 · form4-10072019_091000.xml · nonDerivative · entry 1 Aloi Emiliano Angel · CIK 0001774524 · PRESIDENT AND INTERIM CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000,000 F1 · shares: Award of shares of restricted common stock that commence vesting upon the satisfaction of certain performance conditions, after which the shares shall vest equally over 48 months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.